Equillium, Inc. (EQ) Social Stream



Equillium, Inc. (EQ): $2.70

0.32 (+13.45%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add EQ to Watchlist
Sign Up

Industry: Biotech


Ranked

of 476

in industry

Equillium Inc (EQ) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering EQ.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 4 $18 $12 $13.6 $3.29 313.37%
2022-01-05 5 $18 $12 $13.6 $3.29 313.37%
2022-01-12 5 $14 $12 $12.8 $3.29 289.06%

The Trend in the Analyst Price Target


Over the past 130 days, EQ's average price target has gone down $1.2.

Over the past 40 weeks, EQ's average upside potential has been 153.21%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-21 3 21 12 15.6 5.91 163.96%
2021-09-19 4 18 12 14.0 6.38 119.44%
2021-10-29 5 18 12 13.6 6.31 115.53%
2021-11-15 5 18 12 13.6 5.61 142.42%
2021-12-13 5 18 12 13.6 4.65 192.47%

EQ Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


Over the past 31 days, EQ's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EQ as an investment opportunity.

  • In the context of all US stocks, Equillium Inc's upside potential (average analyst target price relative to current price) is higher than 278.83% of them.
  • In terms of how Equillium Inc fares relative to all US stocks, note that its average analyst price target is higher than 40.53% of that group.
  • In terms of how Equillium Inc fares relative to stocks in the micro market cap category, note that its number of analysts covering the stock is greater than 251.41% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Equillium Inc's variance in analysts' estimates is lower than 14.54% of them.

Stocks similar to Equillium Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ENVB, ENLV, and EDSA.

Is EQ a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.655 seconds.